Iridex (IRIX) EBIT Margin (2010 - 2026)
Iridex's quarterly EBIT Margin came in at 2.75% in Q2 2026, down 102.0% year-on-year from 137.3% in Q2 2025, and down 124.73% quarter-over-quarter from 11.1% in Q1 2026.
Iridex has reported EBIT Margin for 17 years, with the latest figure at 2.75% in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin fell 102.0% year-over-year to 2.75%; the trailing twelve-month figure through Apr 2026 stood at 1.98% (down 450.0% YoY), and the FY2026 full-year result was 1.75%, up 207.0% from the prior year.
- EBIT Margin for Q2 2026 stood at 2.75%, down from 11.1% in the prior quarter.
- The five-year high for EBIT Margin was 46.81% in Q4 2024, with the low at 28.0% in Q1 2024.
- Average EBIT Margin over 5 years is 9.17%, with a median of 12.36% recorded in 2022.
- Year-over-year, EBIT Margin soared 7154 bps in 2024 and tumbled 3571 bps in 2026.
- Tracing IRIX's EBIT Margin over 5 years: stood at 9.28% in 2022, then sank by 167 bps to 24.73% in 2023, then soared by 289 bps to 46.81% in 2024, then sank by 124 bps to 11.3% in 2025, then surged by 76 bps to 2.75% in 2026.
- The last three EBIT Margin figures came in at 2.75% (Q2 2026), 11.1% (Q1 2026), and 11.3% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | -2.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -2.75% |
| Jan 3, 2026 | 11.10% |
| Sep 27, 2025 | -11.30% |
| Jun 28, 2025 | -6.93% |
| Mar 29, 2025 | -1.72% |
| Dec 28, 2024 | 46.81% |
| Sep 28, 2024 | -16.15% |
| Jun 29, 2024 | -20.89% |
| Mar 30, 2024 | -28.00% |
| Dec 30, 2023 | -24.73% |
| Sep 30, 2023 | -13.14% |
| Jul 1, 2023 | -22.51% |
| Apr 1, 2023 | -17.10% |
| Dec 31, 2022 | -9.28% |
| Oct 1, 2022 | -11.58% |
| Jul 2, 2022 | -15.70% |
| Apr 2, 2022 | -17.01% |
| Jan 1, 2022 | -4.19% |
| Oct 2, 2021 | -16.26% |
| Jul 3, 2021 | -8.48% |
| Apr 3, 2021 | -15.39% |
| Sep 26, 2020 | -20.97% |
| Jun 27, 2020 | -44.77% |
| Mar 28, 2020 | -18.32% |
| Dec 28, 2019 | -13.75% |
| Sep 28, 2019 | -17.38% |
| Jun 29, 2019 | -23.67% |
| Mar 30, 2019 | -28.66% |
| Dec 29, 2018 | -25.37% |
| Sep 29, 2018 | -27.03% |
| Jun 30, 2018 | -31.85% |
| Mar 31, 2018 | -38.04% |
| Dec 30, 2017 | -50.94% |
| Sep 30, 2017 | -28.27% |
| Jul 1, 2017 | -27.40% |
| Apr 1, 2017 | -17.72% |
| Dec 31, 2016 | -8.59% |
| Oct 1, 2016 | -12.74% |
| Jul 2, 2016 | -3.31% |
| Apr 2, 2016 | 1.27% |
| Jan 2, 2016 | -12.27% |
| Oct 3, 2015 | 1.46% |
| Jul 4, 2015 | -8.27% |
| Apr 4, 2015 | 3.73% |
| Sep 27, 2014 | 5.99% |
| Jun 28, 2014 | 3.78% |
| Mar 29, 2014 | 5.78% |
| Dec 28, 2013 | 5.25% |
| Sep 28, 2013 | 6.98% |
| Jun 29, 2013 | 5.59% |
| Mar 30, 2013 | 10.03% |
| Dec 29, 2012 | 3.31% |
| Sep 29, 2012 | -7.35% |
| Jun 30, 2012 | -4.14% |
| Mar 31, 2012 | -2.84% |
| Dec 31, 2011 | 3.86% |
| Oct 1, 2011 | 5.84% |
| Jul 2, 2011 | 4.03% |
| Apr 2, 2011 | 3.17% |
| Oct 2, 2010 | 42.59% |
| Jul 3, 2010 | 1.73% |